ARK Stock Commentary: CMPS, TWST, NRIX, XYZ, TRMB, VCYT, GENI, FIG, AMD, TER, P, OKLO, KDK, LUNR, RKLB
Why this is in the vault
Weekly roundup of ARK's own ≥15%-in-a-day movers, filed mainly because it extends the "no company-specific news" pattern (previously tracked only on QSI) to two different names — LUNR and RKLB — the same Friday, plus a same-day AI-infra-capex scare that hit three names (AMD, TER, and "P") on an identical macro narrative despite each reporting strong individual earnings.
⚠️ Sponsorship
ARK Invest is an active fund manager writing about stocks in its own strategies (per the email's own framing: "stocks in our strategies that have appreciated or dropped more than 15% in a day"). All fifteen names in this issue are ARK portfolio holdings; the commentary narrates price moves and business lines without disclosing ARK's position size, cost basis, or whether ARK traded around any of these moves. sponsored: true / sponsor_entity: self per the established ARK Invest pattern in this vault.
Curation section
- Compass Pathways (CMPS), -27% Mon — Fell after a third-party report that non-profit rival Usona filed a psilocybin MDD NDA with the FDA; filing completeness and phase 3 data remain unconfirmed. Mental-health care company accelerating access to psilocybin-based treatment.
- Twist Bioscience (TWST), -15% Mon / -15% Thu — Fell twice this week on continued sector-wide uncertainty about the timing of incremental AI-drug-discovery revenue. Synthetic-biology reagents/tools (oligonucleotides) provider.
- Nurix Therapeutics (NRIX), -41% Wed — Fell after partner Sanofi discontinued SAR448272 (an oral STAT6 degrader) over animal-toxicology issues. Targeted-protein-degradation therapeutics developer.
- Block (XYZ), +15% Wed — Rose on a Q3 beat: 27% YoY gross-profit growth at Cash App, 14% YoY at Square; management raised 2026 adjusted operating income guidance to ~$3.5B and projects 30% YoY growth to $4.58B in 2027.
- Trimble (TRMB), -18% Wed — Fell after cutting full-year organic ARR growth guidance to ~10% from 12-14%, citing a Field Systems white-label exit, weak ag demand, and soft bundled-positioning renewals in construction; AI benefits not expected until H2 2027.
- Veracyte (VCYT; email text reads "VCTY" — likely a typo in ARK's own copy), -54% Thu — Fell on a worse-than-expected Decipher prostate-testing revenue quarter, management citing demand pull-forward from prior guideline revisions plus new low-risk guidelines and competitive noise.
- Genius Sports (GENI), -15% Thu — Fell despite a Q3 revenue/EBITDA beat, as flat Q4 guidance and a deferred 2027 outlook (pushed to March) disappointed investors.
- Figma (FIG), -16% Thu — Fell after Q3 earnings (revenue +43% YoY to $391.4M, raised full-year guidance) as investors weighed AI-adoption upside against AI-product cost: non-GAAP gross margin slipped to 82% from 85%.
- AMD, -17% Thu — Fell in a broader AI-semiconductor selloff on fears that data-center-development restrictions could slow AI infra spending — despite AMD's own 97% YoY Data Center revenue growth that same week on record Instinct GPU and EPYC CPU sales.
- Teradyne (TER), -15% Thu — Fell in the same AI-infra-capex selloff despite reporting 70% YoY revenue growth on record memory and integrated-systems testing demand.
- "Everpure" (P), -16% Thu — Fell in the same selloff, extending prior weakness ahead of its own upcoming earnings; enterprise all-flash storage for cloud/AI workloads.
- Oklo (OKLO), +22% Fri — Rose on a Q3 beat plus a new partnership with US Forged Rings reserving domestic manufacturing capacity for Aurora Powerhouse components, and management citing bipartisan nuclear-energy support. First deployment still slated late 2027/early 2028.
- Kodiak AI (KDK), +29% Fri — Rose on Q3 earnings including a binding DTL Transport deal for 75 unsupervised autonomous trucks; management targets FCF breakeven, >5,000 trucks, and >$1B annualized run-rate revenue exiting 2029.
- Intuitive Machines (LUNR), +21% Fri — Rose on no company-specific news.
- Rocket Lab (RKLB), +15% Fri — Rose on no company-specific news.
Mapping against Ray Data Co
The load-bearing item is a pattern extension, not any single pick: prior ARK notes ([[2026-10-03-ark-invest-stock-commentary-qsi-pacb-sctx]], [[2026-10-10-ark-invest-stock-commentary-qsi-rxrx-twst-txg-almr-pacb]], [[2026-10-23-ark-invest-stock-commentary-iam-qsi-wgs]], [[2026-10-30-ark-invest-stock-commentary-nu-prme-pacb-qsi-blsh]]) logged four straight weeks of QSI moving double digits "on no company-specific news." This week the identical no-catalyst framing appears verbatim on two different names in the same issue — LUNR and RKLB, both up double digits the same Friday. That generalizes the finding from "QSI specifically is noisy" to "ARK's own weekly narration routinely presents unexplained moves as fact regardless of which ticker it lands on" — reinforcing [[project_investing_markov_capital_cycle]]'s standing conclusion to weight ARK commentary low as a signal source, not high.
Separately, AMD, Teradyne, and "Everpure" (P) all fell the same Thursday on one shared macro narrative — fear that data-center-development restrictions could slow AI infrastructure spending — despite each reporting strong individual quarters (AMD +97% YoY Data Center revenue, Teradyne +70% YoY revenue). That is a concrete, dated instance of a market repricing AI-infra names on a capex-digestion/overbuild narrative that overrides company-level fundamentals in a single session — exactly the kind of regime-shift data point the capital-cycle thesis needs to catalog, even though ARK supplies no original analysis here beyond narrating the sell-off.
Mapping is medium: no direct phData / Scribble Works product connection, but two genuine, trackable data points for the standing investing project — the no-news-pattern generalizing beyond one ticker, and a same-day multi-name AI-infra selloff on a shared macro fear. Filing as medium rather than forcing "strong."
Related
- [[2026-11-02-ark-anthropic-s1-training-paying-off]]
- [[2026-10-30-ark-invest-stock-commentary-nu-prme-pacb-qsi-blsh]]
- [[2026-10-23-ark-invest-stock-commentary-iam-qsi-wgs]]
- [[project_investing_markov_capital_cycle]]